In conclusion, this is the first study that investigates the immunohistochemical expression of the IMP3 protein with a correlation with other important parameters (IDH1 mutation and MGMT methylation status) and Ki67 proliferative index in a large series of high-grade gliomas. The gene discussed is MGMT; the disease is glioma.